2024-12-16 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report

**1. Performance Comparison with S&P 500 (VOO):**

Eli Lilly and Co. (LLY) is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products.  Over the period analyzed, LLY's cumulative return (574.84%) significantly outperformed the S&P 500's cumulative return (120.91%). The difference in cumulative returns is 453.9%, placing it at the 72.6th percentile of the historical range of outperformance relative to the S&P 500. This indicates a substantially higher return than the benchmark index.  The provided CAGR data further supports this superior performance, showing consistently high growth rates over multiple years.


**2. Recent Price Movement:**

* **Closing Price:** $789.12
* **5-Day Moving Average:** $794.13
* **20-Day Moving Average:** $782.41
* **60-Day Moving Average:** $845.56

The current price is below all three moving averages, suggesting a potential short-term downward trend.  The significant difference between the current price and the 60-day moving average indicates a notable price decline from recent highs.


**3. Technical Indicators and Expected Return:**

* **RSI:** 64.63 (Slightly above neutral; not overbought)
* **PPO:** 0.377 (Positive, suggesting bullish momentum)
* **20-Day Relative Divergence:** -4.7% (Short-term downward pressure)
* **Expected Return:** 555.1% (This is a remarkably high projected return, significantly exceeding the historical norm and requiring further investigation into its calculation methodology and underlying assumptions. This number needs substantial context and should be treated with extreme caution.)

Given the current price of $789.12 is below the moving averages and the negative relative divergence, the market outlook is currently bearish in the short term. The high expected return needs significant validation.


**4. Recent Earnings Analysis:**

The provided earnings data shows significant volatility in EPS and relatively stable revenue.

* **Revenue Growth:** Revenue shows some fluctuation but generally maintains a high level, indicating consistent business activity.
* **EPS Trends:** EPS is highly variable, with significant fluctuations between quarters.  There's a notable negative EPS in 2023-11-02 and 2024-10-30.  Without understanding the context behind these negative EPS figures, itâ€™s hard to draw conclusive insights.
* **Significant Changes:** The large swings in EPS require further investigation to determine underlying causes.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remains consistently high, with a strong profit margin consistently above 80%.  This reflects robust profitability.
* **Capital and Profitability:** Equity has shown growth, but Return on Equity (ROE) is volatile, ranging from a significant negative value to over 20%.  This instability in ROE needs further examination to understand the reasons behind these fluctuations.


**6. News and Recent Issues:**

No recent (within 2 days) earnings news was provided.  To assess market outlook and analyst opinions, additional data sources are needed.


**7. Overall Analysis:**

LLY has demonstrated exceptional long-term performance significantly exceeding the S&P 500. However, recent price action suggests a potential short-term bearish trend.  While the company shows strong revenue and generally high profit margins, the volatility in EPS and ROE raises concerns requiring further investigation.  The exceptionally high projected return needs clarification and validation.  More information is needed on recent news and analyst opinions to fully assess the current situation.  Investors should carefully consider the significant volatility observed in both earnings and ROE before making any investment decisions.  The provided data alone is insufficient to definitively recommend a buy or sell decision.  Additional research including a thorough analysis of the negative EPS figures, ROE fluctuations and the methodology behind the 555.1% expected return projection is crucial.


**8. Disclaimer:** This report is for informational purposes only and does not constitute investment advice.  The analysis is based solely on the provided data and may not reflect the complete picture.  Consult a qualified financial advisor before making any investment decisions.
